2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Down Syndrome: new trials by email Literature Review of Down Syndrome trials Research Report on Down Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age Placebo, RO5186582 - Down Syndrome | Phase 2 | Terminated | Hoffmann-La Roche | 45 | 2015-10-28 | 2017-07-06 |
| Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial Donepezil hydrochloride (Aricept) - Down Syndrome | Phase 2 | Terminated | Eisai Inc. | 117 | 2008-04-04 | 2021-03-29 |
Abnormalities, Multiple (2) · Chromosome Disorders (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Intellectual Disability (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2)
Donepezil (1)
Eisai Inc. (1) · Hoffmann-La Roche (1)
United States (2)